MECKLER JEFFREY A sold 8.4% of their position (8K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $360.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001506916-26-000001
Director
Since May 2019
-8K
Net shares
Net seller
$360.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8K acquired · 16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8K
Price / share
$16.33
Trade value
$130.64K
% of position
9.1%
5/4/2026
87.50K→95.50K
Common Stock
Direct
Shares
−8K
Price / share
$45.00
Trade value
$360K
% of position
8.4%
5/4/2026
95.50K→87.50K
Total
Net shares
+0.00
Net value
-$229.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | M · Option Exercise | +8K | $16.33 | $130.64K | 9.1% | 87.50K | 95.50K |
| Common Stock Direct | 5/4/2026 | S · Sale | −8K | $45.00 | $360K | 8.4% | 95.50K | 87.50K |
| Total | +0.00 | -$229.36K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
16.33
Held after
0.00
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock8K shares | 5/4/2026 | M · Option Exercise | −8K | 16.33 | — | 0.00 |